Past pandemics suggest some of those exposed to novel coronavirus could face heightened risk for a range of brain diseases and disorders, from depression and psychosis to immune complications of the central nervous system
With support from Amazon Web Services, health care providers are using AI in a clinical research study aimed at speeding the detection of pneumonia, a condition associated with severe COVID-19
With three other UC Health medical centers, NIH-sponsored trial will study whether remdesivir, an investigational antiviral drug, may be a safe and effective agent against the novel coronavirus that causes COVID-19
Some less-than-welcome words and phrases have been added recently to our vocabularies: COVID-19, N95 masks, index case and community spread. Now, of course, there is social distancing. But with the rules changing rapidly on which behaviors will keep us safe from the novel coronavirus, many people are confused about exactly…
UCI Health clinicians have launched a clinical trial to test the efficacy of the antiviral drug remdesivir as a potential therapy for COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2) that has reached pandemic levels across the globe. There are no specific therapeutics approved by the Food and Drug…
Health Media Contacts
Find the best contact for health-related media inquiries.
